Search - tctmd.com

Displaying 41 - 58 of 58

Sort: Relevancy | Date

News Daily News

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

Todd Neale

April 12, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

Presentation ACC 2024

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Presenter: Gervasio A. Lamas

April 07, 2024

News Conference News ACC 2024

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Shelley Wood

April 07, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

News Conference News

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

Yael L. Maxwell

March 26, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

Injectable Semaglutide Shortage Forces Physicians to Pivot

Todd Neale

February 05, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

Advertisement

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Main Results From The Step-hfpef Dm Trial

Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Semaglutide Winning Streak Continues in CKD With FLOW

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Injectable Semaglutide Shortage Forces Physicians to Pivot

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

February 2024 Dispatch for the CV Team

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

January 2024 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content